Physical Function as Assessed by the Liver Frailty Index Remains Stable Over Time in Patients With Hepatocellular Carcinoma Treated With Locoregional Therapies
Abstrak
INTRODUCTION: It is unknown how frailty evolves over time in patients with hepatocellular carcinoma who are treated with locoregional therapies (LRTs). METHODS: We conducted a retrospective study of LRT-treated hepatocellular carcinoma patients with Liver Frailty Index (LFI) assessments. Linear mixed-effects modeling was used to assess the impact of time (modeled linearly per month) and other variables on LFI. RESULTS: Of 201 patients enrolled, median baseline LFI was 3.54. LFI did not change significantly over time from study entry (P = 0.93). DISCUSSION: In our study, LFI remained stable over time after LRT, suggesting that LRT is generally well tolerated.
Penulis (6)
Madeleine D. Hu
Sy Han Chiou
Molly Delk
Cynthia Fenton
Jennifer C. Lai
Michael Li
Format Sitasi
Akses Cepat
PDF tidak tersedia langsung
Cek di sumber asli →- Tahun Terbit
- 2025
- Bahasa
- en
- Total Sitasi
- 2×
- Sumber Database
- CrossRef
- DOI
- 10.14309/ctg.0000000000000854
- Akses
- Open Access ✓